ORCHARD THERAPEUTICS NORTH AMERICA

Lobbying client · Massachusetts · filed 2025 to 2025

Biotechnology company.

$70,000 Reported spend

3 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (68823), not by name.

Firms hired 1

THEGROUP DC, LLC $70,000 3 filings

Reported by year 1 year

2025 $70,000 3 filings

Issues lobbied 1

Health Issues 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Health & Human Services, Dept of (HHS) 2
HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 3 total

4T

THEGROUP DC, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $50,000 income · posted Jan 20, 2026

View → Q3

THEGROUP DC, LLC

3rd Quarter (July 1 - Sep 30) 2025 · $20,000 income · posted Oct 20, 2025

View → RR

THEGROUP DC, LLC

3rd Quarter (July 1 - Sep 30) 2025 · posted Sep 22, 2025

View →

Foreign entities disclosed 2

KYOWA KIRIN INTERNATIONAL, PLC United Kingdom named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0
ORCHARD THERAPEUTICS LIMITED United Kingdom named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.